PTC Therapeutics | PTCT - Market Capitalization


PTC Therapeutics reported $5.3B in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 4.53B 199M Aug/2026
Alnylam Pharmaceuticals USD 40.19B 3.96B Jun/2026
Amgen USD 209.65B 14.21B Aug/2026
BioCryst Pharmaceuticals USD 1.9B 643M Aug/2026
Biogen USD 31.9B 5B Jun/2026
BioMarin Pharmaceutical USD 11.58B 712M Aug/2026
Cytokinetics USD 8.19B 420M Mar/2026
Enanta Pharmaceuticals USD 122M 98M Dec/2024
Gilead Sciences USD 168.68B 11.82B Aug/2026
Incyte USD 26.84B 4.19B Aug/2026
Ionis Pharmaceuticals USD 13.1B 642M Jun/2026
Karyopharm Therapeutics USD 221M 95M Aug/2026
Novartis USD 240.59B 67.17B Jun/2026
Pfizer USD 143.89B 5.44B Aug/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sarepta Therapeutics USD 1.5B 402M Aug/2026
TG Therapeutics USD 7.13B 1.28B Aug/2026
Ultragenyx Pharmaceutical USD 2.12B 1.16B Aug/2026
Vertex Pharmaceuticals USD 121.59B 4.48B Aug/2026
Xencor USD 1.21B 19M Aug/2026